TEVA PHARMACEUTICAL INDUSTRIES LIMITED Interest on Convertible Debt, Net of Tax
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Interest on Convertible Debt, Net of Tax of $0 for the 12-month period ending 2016-12-31, per its 20-F filed 2017-02-15.
Discontinued › Notes › Earnings Per Share
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2017-02-15
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest on convertible debt, net of tax for the quarter ending 2012-03-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest on convertible debt, net of tax for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest on convertible debt, net of tax for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED interest on convertible debt, net of tax for the quarter ending 2011-06-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Interest on Convertible Debt, Net of Tax 3 month | Interest on Convertible Debt, Net of Tax 6 month | Interest on Convertible Debt, Net of Tax 9 month | Interest on Convertible Debt, Net of Tax 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 20-F · filed 2017-02-15 | |||
| 2015-12-31 | $0.00 20-F · filed 2016-02-11 | |||
| 2014-12-31 | $0.00 20-F · filed 2017-02-15 | |||
| 2013-12-31 | $0.00 20-F · filed 2016-02-11 | |||
| 2012-12-31 | $0.00 20-F · filed 2015-02-09 | |||
| 2012-03-31 | $0.00 6-K · filed 2012-05-09 | $0.00 derived: sum of 2 quarters · filed 2014-02-10 | $0.00 derived: sum of 3 quarters · filed 2014-02-10 | $0.00 derived: sum of 4 quarters · filed 2014-02-10 |
| 2011-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2014-02-10 | $0.00 derived: sum of 2 quarters · filed 2014-02-10 | $0.00 derived: sum of 3 quarters · filed 2014-02-10 | $0.00 20-F · filed 2014-02-10 |
| 2011-09-30 | $0.00 6-K · filed 2011-11-02 | $0.00 derived: sum of 2 quarters · filed 2011-11-02 | $0.00 6-K · filed 2011-11-02 | $11.00M derived: sum of 4 quarters · filed 2013-02-12 |
| 2011-06-30 | $0.00 6-K · filed 2011-07-28 | $0.00 6-K · filed 2011-07-28 | $11.00M derived: sum of 3 quarters · filed 2013-02-12 | $22.00M derived: sum of 4 quarters · filed 2013-02-12 |
| 2011-03-31 | $0.00 6-K · filed 2012-05-09 | $11.00M derived: sum of 2 quarters · filed 2013-02-12 | $22.00M derived: sum of 3 quarters · filed 2013-02-12 | $33.00M derived: sum of 4 quarters · filed 2013-02-12 |
| 2010-12-31 | $11.00M derived: 20-F 12 month − 6-K 9 month · filed 2013-02-12 | $22.00M derived: sum of 2 quarters · filed 2013-02-12 | $33.00M derived: sum of 3 quarters · filed 2013-02-12 | $44.00M 20-F · filed 2013-02-12 |
| 2010-09-30 | $11.00M 6-K · filed 2011-11-02 | $22.00M derived: sum of 2 quarters · filed 2011-11-02 | $33.00M 6-K · filed 2011-11-02 | $33.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $11.00M 6-K · filed 2011-07-28 | $22.00M 6-K · filed 2011-07-28 | $22.00M derived: sum of 3 quarters · filed 2012-02-17 | $32.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $11.00M 6-K · filed 2011-05-11 | $11.00M derived: sum of 2 quarters · filed 2012-02-17 | $21.00M derived: sum of 3 quarters · filed 2012-02-17 | $22.00M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2012-02-17 | $10.00M derived: sum of 2 quarters · filed 2012-02-17 | $11.00M derived: sum of 3 quarters · filed 2012-02-17 | $1.00M 20-F · filed 2012-02-17 |
| 2009-09-30 | $10.00M 6-K · filed 2010-11-02 | $11.00M derived: sum of 2 quarters · filed 2010-11-02 | $1.00M 6-K · filed 2010-11-02 | |
| 2009-06-30 | $1.00M 6-K · filed 2010-07-27 | $2.00M 6-K · filed 2010-07-27 | ||
| 2008-12-31 | $5.00M 20-F · filed 2011-02-15 |